Gilde Healthcare Holding B.V. - 01 Aug 2025 Form 4 Insider Report for SHOULDER INNOVATIONS, INC. (SI)

Reporting relationship: 10%+ Owner
Issuer ticker: SI
Reported as of: 01 Aug 2025
Net transaction value: +$1,500,000
SEC form: 4
Accepted by SEC: 05 Aug 2025, 18:37:22 UTC
Prior SEC filing: 30 Jul 2025
Next SEC filing: 03 Aug 2026
Source filing: View source filing
Reporting owner signature: Gilde Healthcare Holding B.V., By: /s/ Edwin de Graaf, Managing Director

Key filing fact

Gilde Healthcare Holding B.V. filed Form 4 for SHOULDER INNOVATIONS, INC. (SI) on 05 Aug 2025.

Key facts

This page summarizes Gilde Healthcare Holding B.V.'s Form 4 filing for SHOULDER INNOVATIONS, INC. (SI).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 05 Aug 2025, 18:37.

Change

Previous filing in this sequence was filed on 30 Jul 2025.
Current net transaction value: +$1,500,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001420106 Primary reporting owner

Gilde Healthcare Holding B.V.

Relationship: 10%+ Owner
Address: STADSPLATEAU 36, UTRECHT, NETHERLANDS
Signature: Gilde Healthcare Holding B.V., By: /s/ Edwin de Graaf, Managing Director
Signature date: 05 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SI transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +1,743,156
Change %
Price
Shares after: 1,743,156
Date: 01 Aug 2025
Ownership: See footnote
Footnotes: F1, F2

SI transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +537,326
Change %: +31%
Price
Shares after: 2,280,482
Date: 01 Aug 2025
Ownership: See footnote
Footnotes: F1, F2

SI transaction

Common Stock

Purchase

Transaction value: $1,500,000
Shares: +100,000
Change %: +4.4%
Price: $15.00
Shares after: 2,380,482
Date: 01 Aug 2025
Ownership: See footnote
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SI transaction Derivative

Series D Convertible Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -33,259,424
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 Aug 2025
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 1,743,156
Exercise price
Footnotes: F1, F2

SI transaction Derivative

Series E Convertible Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -10,252,188
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 Aug 2025
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 537,326
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis without payment or further consideration. There was no expiration date for the shares of preferred stock.

Footnote F2

Held directly by Cooperatieve Gilde Healthcare V U.A. ("Gilde"). Gilde Healthcare V Management B.V. is the managing director of Gilde and has sole voting and dispositive power with respect to the shares held by Gilde. Gilde Healthcare V Management B.V. is owned by Gilde Healthcare Holding B.V. The managing partners of Gilde Healthcare Holding B.V. are Manapouri B.V. (of which Edwin de Graaf is the owner and managing director) and Martemanshurk B.V. (of which Pieter van der Meer is the owner and managing director). Geoff Pardo is a partner at Gilde and may be deemed to share voting and dispositive power with respect to the shares held of record by Gilde. Mr. Pardo disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares.